doi: 10.1007/BF01063121.
Pharmacokinetics of isoniazid and some metabolites in man
- PMID: 978394
- DOI: 10.1007/BF01063121
Item in Clipboard
Pharmacokinetics of isoniazid and some metabolites in man
J Pharmacokinet Biopharm.
1976 Aug.
No abstract available
Similar articles
-
Clinical pharmacokinetics of isoniazid.Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001. Clin Pharmacokinet. 1979. PMID: 391461 Review.
-
Pharmacokinetics of the toxic hydrazino metabolites formed from isoniazid in humans.J Pharmacol Exp Ther. 1985 Dec;235(3):566-70. J Pharmacol Exp Ther. 1985. PMID: 4078724
-
Statistical estimations in pharmacokinetics.J Pharmacokinet Biopharm. 1974 Apr;2(2):123-48. doi: 10.1007/BF01061504. J Pharmacokinet Biopharm. 1974. PMID: 4427218 No abstract available.
-
Pharmacokinetics of isoniazid metabolism in man.J Pharmacokinet Biopharm. 1976 Apr;4(2):83-113. doi: 10.1007/BF01086149. J Pharmacokinet Biopharm. 1976. PMID: 950592 No abstract available.
-
Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis.Ann Intern Med. 1976 Feb;84(2):181-92. doi: 10.7326/0003-4819-84-2-181. Ann Intern Med. 1976. PMID: 766682 Review.
Cited by
-
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling.AAPS J. 2024 Apr 24;26(3):54. doi: 10.1208/s12248-024-00923-9. AAPS J. 2024. PMID: 38658473
-
Plasma and salivary concentrations of isoniazid in man: preliminary findings in two slow acetylator subjects.J Pharmacokinet Biopharm. 1975 Dec;3(6):443-56. doi: 10.1007/BF01059476. J Pharmacokinet Biopharm. 1975. PMID: 1206480 No abstract available.
-
Clinical pharmacokinetics of isoniazid.Clin Pharmacokinet. 1979 Nov-Dec;4(6):401-22. doi: 10.2165/00003088-197904060-00001. Clin Pharmacokinet. 1979. PMID: 391461 Review.
-
PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid.Pharm Res. 2021 Sep;38(9):1485-1496. doi: 10.1007/s11095-021-03095-9. Epub 2021 Sep 13. Pharm Res. 2021. PMID: 34518943
-
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.Pharmaceutics. 2024 Dec 12;16(12):1587. doi: 10.3390/pharmaceutics16121587. Pharmaceutics. 2024. PMID: 39771565 Free PMC article.